Transcriptional and epigenetic regulation of POMC gene expression
- J Drouin, Molecular Genetics, Institut de recherches cliniques de Montréal (IRCM), Montréal, H2W 1R7, Canada
- Correspondence: Jacques Drouin, Email: Jacques.Drouin{at}ircm.qc.ca
Abstract
Expression of the POMC gene integrates numerous inputs that reflect the developmental history of POMC-expressing cells of the pituitary and hypothalamus, as well as their critical role in the endocrine system. These inputs are integrated at specific regulatory sequences within the promoter and pituitary or hypothalamic enhancers of the POMC locus. Investigations of developmental mechanisms and transcription factors responsible for pituitary activation of POMC transcription led to the discovery of the Pitx factors that have critical roles in pituitary development and striking patterning functions in embryonic development. Terminal differentiation of the two pituitary POMC lineages, the corticotropes and melanotropes, is controlled by Tpit; mutations of the human TPIT gene cause isolated ACTH deficiency. Intermediate lobe and melanotrope identity is provided by the pioneer transcription factor Pax7 that remodels chromatin to reveal a new repertoire of enhancers for Tpit action. Many signaling pathways regulate POMC transcription including activation by hypothalamic CRH acting through the orphan nuclear receptors of the Nur family and feedback repression by glucocorticoids and their recptor GR. Transcription factors of the bHLH, Smad, Stat, Etv, NFKB families also mediate signals for control of POMC transcription. Whereas most of these regulatory processes are conserved in different species, there are also notable differences between specific targets for regulation of the human compared to mouse POMC genes.
- Received 20 November 2015
- Revision received 14 January 2016
- Accepted 20 January 2016
- Accepted Preprint first posted online on 20 January 2016